TetraLogic Pharmaceuticals Corporation (TLOG)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 18, 2025, 4:00 PM EDT
Market Cap2.43K
Revenue (ttm)n/a
Net Income (ttm)-40.72M
Shares Out24.32M
EPS (ttm)-1.65
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,200
Average Volume190
Open0.0001
Previous Close0.0001
Day's Range0.0001 - 0.0001
52-Week Rangen/a
Beta32.09
RSI66.46
Earnings Daten/a

About TLOG

TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells. SHAPE is its proprietary histone deacetylase inhibitor for topical use for the treatment of early-stage cuta... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 30
Stock Exchange OTCMKTS
Ticker Symbol TLOG
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.